Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06056063 · ClinicalTrials.gov registry record · NA
Project Looking-Glass Evaluation
A NA study of Cone-Beam Computed Tomography, sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT06056063 is a NA study of Cone-Beam Computed Tomography that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06056063, a NA study of Cone-Beam Computed Tomography, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot study to validate the new design and workflow of Cone-Beam CT imaging for radiation therapy treatment simulation.
Conditions Studied
Interventions
- DEVICE Halcyon 4.0
Study Locations (1)
Pennsylvania
- Perelman Center for Advanced Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-11-19 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06056063
The ClinicalTrials.gov registry entry for NCT06056063 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cone-Beam Computed Tomography appearing as the primary indexed condition, and to 1 intervention - of which Halcyon 4.0 is the first listed.
NCT06056063 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06056063 about?
NCT06056063 is a clinical study titled "Project Looking-Glass Evaluation". Pilot study to validate the new design and workflow of Cone-Beam CT imaging for radiation therapy treatment simulation.
What is the current status of trial NCT06056063?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2023-11-19. Estimated completion is 2026-09-30.
What conditions does trial NCT06056063 study?
This clinical trial studies the following conditions: Cone-Beam Computed Tomography.
What interventions are being tested in trial NCT06056063?
The interventions under investigation include: Halcyon 4.0 (DEVICE).
Who is sponsoring clinical trial NCT06056063?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06056063 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.